Zhengye Biotechnology Holding (ZYBT) Receivables (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Receivables of $5.3 million for Q4 2025, down 51.11% year-over-year from $10.7 million in Q4 2024, and down 17.58% quarter-over-quarter from $6.4 million in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Receivables (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Receivables for 3 consecutive years, with $5.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Receivables fell 51.11% year-over-year to $5.3 million; the TTM figure through Dec 2025 stood at $5.3 million (down 51.11% YoY), while the FY2025 annual figure was $8.4 million, down 22.02% from the prior year.
- Receivables declined to $5.3 million in Q4 2025 per ZYBT's latest filing, from $6.4 million in the prior quarter.
- Across five years, Receivables topped out at $13.1 million in Q4 2023 and bottomed at $5.3 million in Q4 2025.
- Historically, Receivables has averaged $8.9 million across 3 years, with a median of $8.6 million in 2024.
- Annual changes were most pronounced in 2024 — Receivables retreated 17.78% — and 2025, when it plunged 51.11%.
- Zhengye Biotechnology Holding's Receivables stood at $13.1 million in 2023, then slipped by 17.78% to $10.7 million in 2024, then slumped by 51.11% to $5.3 million in 2025.
- Business Quant data shows ZYBT's Receivables at $5.3 million in Q4 2025, $6.4 million in Q2 2025, and $10.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.08 Bn |
| 10 | Zhengye Biotechnology Holding | 85.23 Mn | 77.91 Mn | - | 5.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.25 Mn |
| Jun 30, 2025 | 6.37 Mn |
| Dec 31, 2024 | 10.74 Mn |
| Dec 31, 2023 | 13.07 Mn |